Hyundai Pharmaceutical Co., Ltd. (004310.KS)

KRW 3710.0

(-2.62%)

Long Term Debt Summary of Hyundai Pharmaceutical Co., Ltd.

  • Hyundai Pharmaceutical Co., Ltd.'s latest annual long term debt in 2023 was 580.64 Million KRW , down -94.25% from previous year.
  • Hyundai Pharmaceutical Co., Ltd.'s latest quarterly long term debt in 2024 Q3 was 14.66 Billion KRW , up 7.05% from previous quarter.
  • Hyundai Pharmaceutical Co., Ltd. reported annual long term debt of 10.09 Billion KRW in 2022, down -34.15% from previous year.
  • Hyundai Pharmaceutical Co., Ltd. reported annual long term debt of 15.32 Billion KRW in 2021, up 7329.77% from previous year.
  • Hyundai Pharmaceutical Co., Ltd. reported quarterly long term debt of 14.66 Billion KRW for 2024 Q3, up 7.05% from previous quarter.
  • Hyundai Pharmaceutical Co., Ltd. reported quarterly long term debt of 13.7 Billion KRW for 2024 Q2, up 1370000000100.0% from previous quarter.

Annual Long Term Debt Chart of Hyundai Pharmaceutical Co., Ltd. (2023 - 2007)

Historical Annual Long Term Debt of Hyundai Pharmaceutical Co., Ltd. (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 580.64 Million KRW -94.25%
2022 10.09 Billion KRW -34.15%
2021 15.32 Billion KRW 7329.77%
2020 206.25 Million KRW 104.99%
2019 -4.13 Billion KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%
2015 - KRW 0.0%
2014 - KRW 0.0%
2013 - KRW 0.0%
2012 - KRW 0.0%
2011 - KRW 0.0%
2010 - KRW 0.0%
2009 - KRW 0.0%
2008 - KRW 0.0%
2007 - KRW 0.0%

Peer Long Term Debt Comparison of Hyundai Pharmaceutical Co., Ltd.

Name Long Term Debt Long Term Debt Difference
Yuyu Pharma, Inc. 13.64 Billion KRW 95.743%
Dong-A Socio Holdings Co., Ltd. 202.06 Billion KRW 99.713%
Ildong Holdings Co., Ltd. 29.87 Billion KRW 98.057%
HANDOK Inc. 123.78 Billion KRW 99.531%
Kukje Pharma Co., Ltd. 475.74 Million KRW -22.05%
Yuhan Corporation 60.23 Billion KRW 99.036%
Dong-A ST Co., Ltd. 161.99 Billion KRW 99.642%
SAMSUNG PHARM. Co., LTD. 101.81 Million KRW -470.28%
Hanmi Pharm. Co., Ltd. 82.02 Billion KRW 99.292%
Hanall Biopharma Co.,Ltd 590.3 Million KRW 1.637%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW 90.403%
Dong Sung Bio Pharm.Co.,Ltd. 18.52 Billion KRW 96.865%
MYUNGMOON Pharm co.,Ltd 12.58 Billion KRW 95.386%
Hana Pharm Co., Ltd. 1.59 Billion KRW 63.683%
Yuyu Pharma, Inc. 13.64 Billion KRW 95.743%
Ilsung Pharmaceuticals Co., Ltd. 119.67 Million KRW -385.172%
REYON Pharmaceutical Co., Ltd. 121 Billion KRW 99.52%
Aprogen pharmaceuticals,Inc. 32 Billion KRW 98.185%
JW Holdings Corporation 20.65 Billion KRW 97.189%
Ildong Pharmaceutical Co., Ltd. 14.82 Billion KRW 96.083%
Chong Kun Dang Pharmaceutical Corp. 30 Billion KRW 98.065%
JW Pharmaceutical Corporation 30 Billion KRW 98.065%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -165.182%
Samil Pharmaceutical Co.,Ltd 49.56 Billion KRW 98.829%
Jeil Pharmaceutical Co.,Ltd 4.45 Billion KRW 86.958%
Yuyu Pharma, Inc. 13.64 Billion KRW 95.743%
Kwang Dong Pharmaceutical Co., Ltd. 19.02 Billion KRW 96.948%
Daewoong pharmaceutical Co.,Ltd 93.41 Billion KRW 99.378%
JW Pharmaceutical Corporation 30 Billion KRW 98.065%
Yuhan Corporation 60.23 Billion KRW 99.036%
Jeil Pharma Holdings Inc 10.5 Billion KRW 94.47%
Yungjin Pharm. Co., Ltd. 40.37 Billion KRW 98.562%
Suheung Co., Ltd. 74 Billion KRW 99.215%
JW Pharmaceutical Corporation 30 Billion KRW 98.065%
Samjin Pharmaceuticals Co., Ltd. 4.16 Billion KRW 86.064%
Korea United Pharm Inc. 10.96 Billion KRW 94.703%
CKD Bio Corp. 69.43 Billion KRW 99.164%
Daewon Pharmaceutical Co., Ltd. 34.57 Billion KRW 98.321%
Dongwha Pharm.Co.,Ltd 16.12 Billion KRW 96.4%
Whan In Pharm Co.,Ltd. 307.05 Million KRW -89.101%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -165.182%
Chong Kun Dang Holdings Corp. 72.11 Billion KRW 99.195%
Boryung Corporation 151.7 Billion KRW 99.617%
Bukwang Pharmaceutical Co., Ltd. 78.52 Billion KRW 99.261%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW 90.403%
JW Lifescience Corporation 168 Million KRW -245.623%